Predicting Probability of Response to Tumor Necrosis Factor Inhibitors for Individual Patients With Ankylosing Spondylitis
Work
Year: 2022
Type: article
Abstract: Tumor necrosis factor inhibitors (TNFis) have revolutionized the management of ankylosing spondylitis (AS); however, the lack of notable clinical responses in approximately one-half of patients sugges... more
Source: JAMA Network Open
Institutions Columbia University Irving Medical Center, Rheumatology Consultants, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, AstraZeneca (United States)
Cites: 40
Cited by: 19
Related to: 10
FWCI: 5.477
Citation percentile (by year/subfield): 87
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $3,000